Elevation of trimethylamine-N-oxide in chronic kidney disease: Contribution of decreased glomerular filtration rate
In one study, semaglutide 2.4 mg (Wegovy/Ozempic) plus lifestyle intervention produced an average weight loss of 14.9% of body weight over 68 weeks [14, 13]
Declarations Authors contributions Made equal contributions to writing and critically revising the manuscript: Balasubramaniam S, Yaplito-Lee J Availability of data and materials Not applicable
Intended for use by registered medical practitioners
Conclusion: These post-hoc analyses, approximating AMT DR/ER efficacy as a first/early add-on to levodopa, showed OFF and dyskinesia reduction, and consequent ON time improvement without troublesome dyskinesia, that were similar to, or larger than the overall trial
This supports gut health and maximizes the supplement's efficacy, making it a valuable addition for athletes and individuals with high physical demands